Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Molecular Oncology|August 2, 2024
A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cellsJavier Villoch-Fernandez, Nicole Martínez-García, Marta Martín-López, et al.
Journal of Gastroenterology|April 9, 2017
Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort studyRichard Parker, Gene Im, Fiona Jones, et al.
Frontiers in Psychology|March 17, 2022
Involving Older Adults During COVID-19 Restrictions in Developing an Ecosystem Supporting Active Aging: Overview of Alternative Elicitation Methods and Common Requirements From Five European CountriesKerli Mooses, Mariana Camacho, Filippo Cavallo, et al.
Plos One|January 28, 2021
High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory responseMiguel Ángel López Zúñiga, Aida Moreno-Moral, Ana Ocaña-Granados, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2025
A Large-Scale Analysis of Autologous Stem Cell Transplantation for Multiple Myeloma Patients Older than 65 YearsAdolfo Jesús Sáez-Marín, Gema Hernandez-Ibarbu, Lucia Medina Alba, et al.
Advances in Therapy|May 12, 2025
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect ComparisonNoemi Puig, Joris Diels, Suzy van Sanden, et al.
European Journal of Haematology|July 26, 2020
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignanciesJosé María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, et al.
Journal for Immunotherapy of Cancer|March 6, 2026
Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myelomaMagdalena Corona, Roberto García-Vicente, Adolfo Jesús Saez-Marin, et al.
British Journal of Haematology|June 4, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvementCarlos Jimenez-Mira, Natalia Tovar, Núria Martínez-Cibrián, et al.
European Journal of Haematology|December 6, 2019
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab eraAntonio Gutierrez, Leyre Bento, Antonio Diaz-Lopez, et al.
Pageof 6